Nadiya is a Senior Director, Venture Investments, at J&J Innovation – JJDC, Inc. Prior to joining JJDC, Nadiya was a Principal in the Biotechnology team at M Ventures, the corporate venture arm of Merck KGaA Darmstadt, Germany, where she led investments across both Healthcare and Life Sciences and held Board seats in a number of portfolio companies.

Before transitioning to venture investing, Nadiya was a Manager in the Health & Life Sciences practice at global strategy consulting firm Oliver Wyman. In this role, she advised corporate healthcare clients, health systems, pharma, and digital health companies on strategic transformation across EMEA, Asia Pacific, and Emerging Markets, and supported M&A deals through pre-transaction assessments of value and risk.

Nadiya holds a PhD in Biochemistry from the University of Oxford, B.Sc. in Organic Chemistry and dual M.Sc. degrees in Enzymology and in Nanobiomaterials & Nanobiotechnology from Lomonosov Moscow State University.